Form DRS - Draft Registration Statement:
SEC Accession No. 0000912057-19-000021
Filing Date
2019-01-17
Accepted
2019-01-17 17:27:26
Documents
33

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2283703
2 filename2.htm EX-3.1 161707
3 filename3.htm EX-3.3 57519
4 filename4.htm EX-10.1 415462
5 filename5.htm EX-10.5 96935
6 filename6.htm EX-10.7 1457113
7 filename7.htm EX-21.1 1681
8 g239315.jpg GRAPHIC 86310
9 g249259.jpg GRAPHIC 34682
10 g253653.jpg GRAPHIC 71881
11 g273067.jpg GRAPHIC 27028
12 g292183.jpg GRAPHIC 107823
13 g310115.jpg GRAPHIC 30979
14 g311426.jpg GRAPHIC 55400
15 g354508.jpg GRAPHIC 132355
16 g363172.jpg GRAPHIC 92564
17 g374807.jpg GRAPHIC 28117
18 g387862.jpg GRAPHIC 106420
19 g401598.jpg GRAPHIC 57934
20 g419522kw05i001.jpg GRAPHIC 81765
21 g471160.jpg GRAPHIC 80131
22 g480743.jpg GRAPHIC 15594
23 g524389.jpg GRAPHIC 53424
24 g685001.jpg GRAPHIC 120276
25 g815469.jpg GRAPHIC 79480
26 g819588.jpg GRAPHIC 26715
27 g894662.jpg GRAPHIC 92336
28 g919117.jpg GRAPHIC 91379
29 g977903.jpg GRAPHIC 45702
30 g991841.jpg GRAPHIC 99088
31 g997105.jpg GRAPHIC 81005
32 g1011603.jpg GRAPHIC 92717
33 g1014474.jpg GRAPHIC 90074
  Complete submission text file 0000912057-19-000021.txt   7069141
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 202-525-8399
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-02467 | Film No.: 19531610
SIC: 2834 Pharmaceutical Preparations